Explained: Why WHO's emergency usage listing is important for Bharat Biotech's COVAXIN
1Both COVID-19 vaccine doses needed for good protection against B16172 variant
2Health ministry to buy 30 cr COVID-19 vaccine doses from Biological-E for Rs 1,500 cr
3New York's Excelsior Pass is USA's first COVID-19 vaccine passport
4Heads of four global organisations appeal to world leaders for COVID-19 vaccine equality
5Manufacturing and testing a batch of COVAXIN takes 120 days, says Bharat Biotech
6Hyderabad-based Biological E to manufacture Canadian firm Providence's COVID 19 vaccine
7WHO says only one strain of B.1.617 COVID-19 mutation first found in India is 'variant of concern'
8Too good to be true? Pfizer is working on a pill that could potentially treat COVID-19
9COVID-19 variants to be identified by Greek letters: Process of naming pathogens has often been controversial
10
 (1).jpg)
